Last CNY5.95 CNY
Change Today -0.07 / -1.16%
Volume 14.9M
As of 2:05 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

tianjin tianyao pharm-a (600488) Snapshot

Open
CNY6.02
Previous Close
CNY6.02
Day High
CNY6.02
Day Low
CNY5.87
52 Week High
10/16/14 - CNY6.66
52 Week Low
01/14/14 - CNY3.82
Market Cap
5.7B
Average Volume 10 Days
22.4M
EPS TTM
CNY0.06
Shares Outstanding
960.9M
EX-Date
05/21/14
P/E TM
97.5x
Dividend
CNY0.02
Dividend Yield
0.30%
Current Stock Chart for TIANJIN TIANYAO PHARM-A (600488)

Related News

No related news articles were found.

tianjin tianyao pharm-a (600488) Related Businessweek News

No Related Businessweek News Found

tianjin tianyao pharm-a (600488) Details

Tianjin Tianyao Pharmaceuticals Co., Ltd. researches, manufactures, and sells pharmaceutical APIs in Asia. The company primarily offers corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. Its product portfolio includes bulk drugs, such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, spironolactone, methylprednisolone hemisuccinate, hydrocortisone butyrate, hydrocortisone, hydrocortisone acetate, methylprednisolone, triamcinolone, bucinnazine hydrochloride, and flunarizine hydrochloride. Tianjin Tianyao Pharmaceuticals Co., Ltd. also offers formulations, which include triamcinolone, dexamethasone acetate, prednisone acetate, and methylprednisolone tablets. The company also exports its products. Tianjin Tianyao Pharmaceuticals Co., Ltd. is based in Tianjin, China.

tianjin tianyao pharm-a (600488) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianjin tianyao pharm-a (600488) Key Developments

Tianjin Tianyao Pharmaceuticals Co., Ltd., Board Meeting, Nov 15, 2014

Tianjin Tianyao Pharmaceuticals Co., Ltd., Board Meeting, Nov 15, 2014. Agenda: To discuss and approve issues including the proposal of electing Chair of Directorate; and to consider the proposal of appointing General Manager and the proposal of appointing Secretary to Directorate.

Tianjin Tianyao Pharmaceutical Co., Ltd. Announces Earnings Results for the First Three Quarters of 2014

Tianjin Tianyao Pharmaceutical Co., Ltd. announced earnings results for the first three quarters of 2014. The company revealed net profit attributable to shareholders of CNY 58.785 million in the first three quarters, rising 11.17% from CNY 52.88 million a year earlier. Basic EPS were CNY 0.061, climbing 5.17% from CNY 0.058 a year ago. Weighted average return on net assets of 2.53%.

Tianjin Tianyao Pharmaceuticals Co., Ltd., Board Meeting, Oct 28, 2014

Tianjin Tianyao Pharmaceuticals Co., Ltd., Board Meeting, Oct 28, 2014. Agenda: To discuss and approve issues including the third quarter report of 2014, the report on changing accounting policy; and to discuss and approve the proposal of term change election of directorate.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600488:CH CNY5.95 CNY -0.07

600488 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600488.
View Industry Companies
 

Industry Analysis

600488

Industry Average

Valuation 600488 Industry Range
Price/Earnings 100.0x
Price/Sales 4.1x
Price/Book 2.4x
Price/Cash Flow 99.2x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TIANYAO PHARM-A, please visit www.kingyork.biz/tianyaoyaoyeen. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.